Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.

Florentin J, Aouar B, Dental C, Thumann C, Firaguay G, Gondois-Rey F, Soumelis V, Baumert TF, Nunès JA, Olive D, Hirsch I, Stranska R.

Blood. 2012 Nov 29;120(23):4544-51. doi: 10.1182/blood-2012-02-413286. Epub 2012 Oct 10.

2.

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.

Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor CG, de Vries IJ, Adema GJ.

Blood. 2008 Apr 15;111(8):4245-53. doi: 10.1182/blood-2007-03-081398. Epub 2008 Feb 7.

3.

BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.

Jähn PS, Zänker KS, Schmitz J, Dzionek A.

Cell Immunol. 2010;265(1):15-22. doi: 10.1016/j.cellimm.2010.06.005. Epub 2010 Jul 6.

PMID:
20673884
4.

Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.

Dental C, Florentin J, Aouar B, Gondois-Rey F, Durantel D, Baumert TF, Nunes JA, Olive D, Hirsch I, Stranska R.

J Virol. 2012 Jan;86(2):1090-6. doi: 10.1128/JVI.05444-11. Epub 2011 Nov 16.

5.

TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.

Wu P, Wu J, Liu S, Han X, Lu J, Shi Y, Wang J, Lu L, Cao X.

Clin Immunol. 2008 Oct;129(1):40-8. doi: 10.1016/j.clim.2008.06.004. Epub 2008 Aug 5.

PMID:
18684674
6.

Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1.

Gondois-Rey F, Dental C, Halfon P, Baumert TF, Olive D, Hirsch I.

PLoS One. 2009;4(2):e4319. doi: 10.1371/journal.pone.0004319. Epub 2009 Feb 2.

7.

Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G.

J Immunol. 2006 Nov 15;177(10):6758-68.

8.

CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.

Zhang S, Kodys K, Babcock GJ, Szabo G.

Hepatology. 2013 Sep;58(3):940-9. doi: 10.1002/hep.25827. Epub 2013 Jan 18.

9.

Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.

Blomberg S, Eloranta ML, Magnusson M, Alm GV, Rönnblom L.

Arthritis Rheum. 2003 Sep;48(9):2524-32.

10.

Human C-type lectin domain family 4, member C (CLEC4C/BDCA-2/CD303) is a receptor for asialo-galactosyl-oligosaccharides.

Riboldi E, Daniele R, Parola C, Inforzato A, Arnold PL, Bosisio D, Fremont DH, Bastone A, Colonna M, Sozzani S.

J Biol Chem. 2011 Oct 14;286(41):35329-33. doi: 10.1074/jbc.C111.290494. Epub 2011 Aug 31.

11.

Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production.

Fanning SL, George TC, Feng D, Feldman SB, Megjugorac NJ, Izaguirre AG, Fitzgerald-Bocarsly P.

J Immunol. 2006 Nov 1;177(9):5829-39.

12.
13.

DCIR interacts with ligands from both endogenous and pathogenic origin.

Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.

Immunol Lett. 2014 Mar-Apr;158(1-2):33-41. doi: 10.1016/j.imlet.2013.11.007. Epub 2013 Nov 14.

PMID:
24239607
14.

Inhibitory effects of human immunodeficiency virus gp120 and Tat on CpG-A-induced inflammatory cytokines in plasmacytoid dendritic cells.

Fang M, Xu N, Shao X, Yang J, Wu N, Yao H.

Acta Biochim Biophys Sin (Shanghai). 2012 Sep;44(9):797-804. doi: 10.1093/abbs/gms062. Epub 2012 Jul 19.

PMID:
22814248
15.

Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.

Sanna A, Huang YM, Arru G, Fois ML, Link H, Rosati G, Sotgiu S.

Mult Scler. 2008 Nov;14(9):1199-207. doi: 10.1177/1352458508094401. Epub 2008 Jul 24.

PMID:
18653740
16.

Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.

Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G.

J Leukoc Biol. 2007 Sep;82(3):497-508. Epub 2007 Jun 12.

PMID:
17565046
17.

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O'Bar A, Agouna-Deciat O, Klucar P, Thompson-Snipes L, Zurawski S, Reiter Y, Palucka AK, Zurawski G, Banchereau J.

Blood. 2010 Sep 9;116(10):1685-97. doi: 10.1182/blood-2010-01-264960. Epub 2010 Jun 7.

18.

DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production.

Meyer-Wentrup F, Cambi A, Joosten B, Looman MW, de Vries IJ, Figdor CG, Adema GJ.

J Leukoc Biol. 2009 Mar;85(3):518-25. doi: 10.1189/jlb.0608352. Epub 2008 Nov 21.

PMID:
19028959
19.
20.

Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.

Riboldi E, Daniele R, Cassatella MA, Sozzani S, Bosisio D.

Immunobiology. 2009;214(9-10):868-76. doi: 10.1016/j.imbio.2009.06.016. Epub 2009 Jul 4.

PMID:
19577819

Supplemental Content

Support Center